Case report: verapamil-induced subacute cutaneous lupus erythematosus.

Boaz Kurtis, Matthew J. Larson, Mai P. Hoang, Jack B. Cohen

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Calcium-channel blockers (CCB), including verapamil, nifedipine, and diltiazem, are one of the most widely prescribed class of drugs in the treatment of cardiovascular disease. In the last several years, CCBs have been linked with a distinct cutaneous subset in the lupus spectrum, subacute cutaneous lupus erythematosus (SCLE), and we describe a case induced by verapamil.

Original languageEnglish (US)
Pages (from-to)506-508
Number of pages3
JournalJournal of drugs in dermatology : JDD
Issue number4
StatePublished - 2005

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'Case report: verapamil-induced subacute cutaneous lupus erythematosus.'. Together they form a unique fingerprint.

Cite this